Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease

por Krens, L. L., Baas, J. M., Guchelaar, H. J., Gelderblom, H.
Publicado 2017

Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1

por Heitland, I, Klumpers, F, Oosting, R S, Evers, D J J, Leon Kenemans, J, Baas, J M P
Publicado 2012

Genetic polymorphisms of the dopamine and serotonin systems modulate the neurophysiological response to feedback and risk taking in healthy humans

por Heitland, I., Oosting, R. S., Baas, J. M. P., Massar, S. A. A., Kenemans, J. L., Böcker, K. B. E.
Publicado 2012

The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD

por Leen, N.A., de Weijer, A.D., van Rooij, S.J.H., Kennis, M., Baas, J.M.P., Geuze, E.
Publicado 2022

Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients

por Baas, J. M., Krens, L. L., ten Tije, A. J., Erdkamp, F., van Wezel, T., Morreau, H., Gelderblom, H., Guchelaar, H. J.
Publicado 2015

Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine

por Baas, J. M. P., Mol, N., Kenemans, J. L., Prinssen, E. P., Niklson, I., Xia-Chen, C., Broeyer, F., van Gerven, J.
Publicado 2009

Erratum to: Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine

por Baas, J. M. P., Mol, N., Kenemans, J. L., Prinssen, E. P., Niklson, I., Xia-Chen, C., Broeyer, F., van Gerven, J.
Publicado 2010